Showing results (281-290 of 331) with videos related to
Sort By:
Pageof 34
Neuromuscular Disorders : NMD|July 4, 2012
Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinasesDawn A Delfín, Kara E Zang, Kevin E Schill, et al.Gynecologic Oncology Reports|February 20, 2025
Step-by-step combination of 99mTc and ICG with endoscopic near infrared cameras in SLN mapping early-stage vulvar cancerA Rafael Guijarro-Campillo, Pablo Padilla-Iserte, Víctor Lago, et al.Scientific Reports|December 14, 2016
Fossil record of stem groups employed in evaluating the chronogram of insects (Arthropoda: Hexapoda)Yan-Hui Wang, Michael S Engel, José A Rafael, et al.RSC Advances|August 28, 2024
Upgrading furfural to bio-fuels using supported molybdenum carbides: study of the support effectLeticia F Sosa, Priscilla M de Souza, Raphaela A Rafael, et al.Plos One|February 20, 2014
Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophyPaul M L Janssen, Jason D Murray, Kevin E Schill, et al.Gynecologic Oncology|February 26, 2026
Rectosigmoidectomy versus pelvic peritonectomy in the management of seromuscular involvement of superficial rectal wall tumors in advanced-stage ovarian cancer at complete interval cytoreductive surgeryA Rafael Guijarro-Campillo, Alida González-Gil, Elena Gil-Gómez, et al.The New England Journal of Medicine|November 18, 2000
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunctionR J Kim, E Wu, A Rafael, et al.Human Molecular Genetics|March 11, 1999
Characterization of dystrophin and utrophin diversity in the mouseC N Lumeng, S F Phelps, J A Rafael, et al.Journal of Equine Veterinary Science|August 8, 2025
Management of retained fetal membranes by umbilical vessel infusion in mares submitted to elective C-sectionMarcos Eduardo Neto, Bruna R Curcio, Leandro A Rafael, et al.European Journal of Neurology|April 29, 2020
Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trialT H Brannagan, A K Wang, T Coelho, et al.Pageof 34